Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-sales ratio

Latest
10.53
↑ 326% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
2.47
Historical baseline
PeriodValueYoY Change
202510.53+55.3%
20246.78-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-